- Home
- WPP vs SNN Comparison
WPP vs SNN Comparison
Compare WPP & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPP
- SNN
- Stock Information
- Founded
- WPP 1985
- SNN 1856
- Country
- WPP United Kingdom
- SNN United Kingdom
- Employees
- WPP N/A
- SNN N/A
- Industry
- WPP Advertising
- SNN Industrial Specialties
- Sector
- WPP Consumer Discretionary
- SNN Health Care
- Exchange
- WPP Nasdaq
- SNN Nasdaq
- Market Cap
- WPP 9.5B
- SNN 11.0B
- IPO Year
- WPP N/A
- SNN 1999
- Fundamental
- Price
- WPP $45.13
- SNN $25.30
- Analyst Decision
- WPP
- SNN Strong Buy
- Analyst Count
- WPP 0
- SNN 1
- Target Price
- WPP N/A
- SNN N/A
- AVG Volume (30 Days)
- WPP 203.3K
- SNN 1.1M
- Earning Date
- WPP 02-20-2025
- SNN 02-25-2025
- Dividend Yield
- WPP 6.07%
- SNN 2.97%
- EPS Growth
- WPP N/A
- SNN 39.77
- EPS
- WPP 0.23
- SNN 0.35
- Revenue
- WPP $18,768,309,180.00
- SNN $5,642,000,000.00
- Revenue This Year
- WPP N/A
- SNN $6.24
- Revenue Next Year
- WPP N/A
- SNN $4.92
- P/E Ratio
- WPP $37.99
- SNN $35.74
- Revenue Growth
- WPP N/A
- SNN 5.48
- 52 Week Low
- WPP $43.02
- SNN $23.65
- 52 Week High
- WPP $57.37
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- WPP 25.05
- SNN 57.67
- Support Level
- WPP $44.11
- SNN $23.69
- Resistance Level
- WPP $44.80
- SNN $24.82
- Average True Range (ATR)
- WPP 0.74
- SNN 0.44
- MACD
- WPP -0.47
- SNN 0.13
- Stochastic Oscillator
- WPP 17.29
- SNN 47.20
About WPP WPP plc
Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.